Tribio InVivoMAb Anti-hEGFR & mCD3e Bispecific Antibody (TBS10470)
$479.00 – $1,919.00
| SKU | Stock | SIZE (mg) | Price | Quantity | ||
|---|---|---|---|---|---|---|
| TBS10470-100 | Yes | 100 UG | $479.00 | |||
| TBS10470-1 | Yes | 1 MG | $1,919.00 |
- Description
- Terms
- Additional information
- Reviews (0)
Description
Description: Tribio EGFR & CD3E InVivoMAb Bispecific Antibody targets EGFR on tumor cells and CD3E on T cells to redirect T cell–mediated killing of EGFR-positive cancer cells. Used in cancer immunotherapy research to study T cell engagement and tumor killing.
Applications: FuncS
Species reactivity: Human, Mouse
Host species: Mouse
Target: Bispecific, Epidermal growth factor receptor, 2.7.10.1, Proto-oncogene c-ErbB-1, Receptor tyrosine-protein kinase erbB-1, EGFR, ERBB, ERBB1, HER1, T-cell surface glycoprotein CD3 epsilon chain, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, Cd3e
Isotype: IgG
Accession/UniProt: P00533 & P22646
Concentration: 3 mg/ml
Purity: >95%
Formulation: Liquid
Storage buffer: 0.01M PBS, pH 7.4
Purification: Protein A/G purified from cell culture supernatant.
Clonality: Monoclonal
Storage: Avoid repeated freeze-thaw cycles. -20°C for 12 months; -80°C for long-term storage.
Research use only.
Additional information
| SIZE (mg) | 1 MG, 100 UG |
|---|
Be the first to review “Tribio InVivoMAb Anti-hEGFR & mCD3e Bispecific Antibody (TBS10470)”
You must be logged in to post a review.
Reviews
There are no reviews yet.